APPLICATION
ANDA200154
TYPE
ANDA
ORIGINAL APPROVAL
2012-02-03
LATEST ACTION
2024-08-28
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CISATRACURIUM BESYLATE PRESERVATIVE FREEPrescription
CISATRACURIUM BESYLATE EQ 10MG BASE/ML · INJECTABLE · INJECTION
CISATRACURIUM BESYLATE PRESERVATIVE FREEPrescription
CISATRACURIUM BESYLATE EQ 2MG BASE/ML · INJECTABLE · INJECTION
Approval history
2024-08-28Labeling · Supplement 13 · standardAP
2020-07-23Labeling · Supplement 9 · standardAP
2017-12-27Labeling · Supplement 8 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.